Beyond its established role in hematologic recovery, sargramostim has shown potential in immune modulation. It may reverse immune suppression in sepsis, trauma, and acute respiratory distress syndrome (ARDS), including COVID-19. Studies suggest its use as an adjuvant in vaccines, resistant fungal infections, and conditions like autoimmune pulmonary alveolar proteinosis. Its distinct mechanism offers advantages over rhu G-CSF, with a lower risk of lung injury during infections, reinforcing its value in diverse clinical scenarios.
Lazarus, H.M., Ragsdale, C.E., Gale, R.P., and Lyman, G.H., 2021. Sargramostim (rhu GM-CSF) as cancer therapy (systematic review) and an immunomodulator: A drug before its time? Frontiers in Immunology.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Sargamostim 0.25 by Swiss Remedies, consult with your doctor or healthcare professional.
Lazarus, H.M., Ragsdale, C.E., Gale, R.P., and Lyman, G.H., 2021. Sargramostim (rhu GM-CSF) as cancer therapy (systematic review) and an immunomodulator: A drug before its time? Frontiers in Immunology.
Lazarus, H.M., Ragsdale, C.E., Gale, R.P., and Lyman, G.H., 2021. Sargramostim (rhu GM-CSF) as cancer therapy (systematic review) and an immunomodulator: A drug before its time? Frontiers in Immunology.
Lazarus, H.M., Ragsdale, C.E., Gale, R.P., and Lyman, G.H., 2021. Sargramostim (rhu GM-CSF) as cancer therapy (systematic review) and an immunomodulator: A drug before its time? Frontiers in Immunology.
Home
